Results 251 to 260 of about 109,370 (265)

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

Circulation, 2012
Fausto Castriota, Pascal Vranckx, Jlenia Marchesini   +2 more
exaly  

Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents

Circulation, 2009
KRISTIAN Filion
exaly  

Antiplatelet Therapy as a Risk Factor for Microbleeds in Intracerebral Hemorrhage Patients: Analysis Using Specific Antiplatelet Agents

Journal of Stroke and Cerebrovascular Diseases, 2013
Masayasu Matsumoto, Eiichi Nomura, Eiji Imamura   +2 more
exaly  

Characterization of Antiplatelet Properties of Silver Nanoparticles

ACS Nano, 2009
Sunil Kumar Singh, Debabrata Dash, Siddhartha Shrivastava   +2 more
exaly  

Assessment of antiplatelet activity of 2-aminopyrimidines

European Journal of Medicinal Chemistry, 2012
R Ramajayam, M R Yadav
exaly  

Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome

Thrombosis Research, 2009
Mauricio G Cohen, Don A Gabriel
exaly  

Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy

Trends in Pharmacological Sciences, 2017
Michael Holinstat
exaly  

Bioactive peptides and proteins as alternative antiplatelet drugs

Medicinal Research Reviews, 2019
Kannan Rr Rengasamy, Seyed Mohammad Nabavi, Haroon Khan   +2 more
exaly  

Oral Antiplatelet Therapy

JAMA, 2005
Richard A, Bernstein, Gregory W, Albers
openaire   +2 more sources

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

Circulation, 2010
Salvatore Brugaletta, Victoria Martin Yuste, Juan Casanova   +2 more
exaly